Report received indicated the pt experienced a red, dry, itchy rash underneath the device.Rash is worse underneath the adhesive border.The pt experienced the condition during a period of 4-6 weeks prior to complaint receipt.Pt preps with powder and anti-sting spray.Patient treated with antifungal powder with little effect.Pt used cortisone cream and removed the tape border.Rash diminished but still extant under the device advised to perform patch test.Pt outcome was not noted.
|
Convatec is submitting this report as a result of remediation activities related to the fda (b)(4) issued (b)(4) 2014.Device(s) listed in this report is (are) used for treatment, not diagnosis.Any additional info received regarding this event after filing this report shall be field on a supplemental mdr.The submission of this report by convatec or related info to the fda and its release by the fda, does not reflect an admission by convatec, or a conclusion by the fda that this report or related info that convatec, their employees, or the convatec device caused or contributed to the reportable event.Analysis is taken from a trending report of evaluations or adverse events finalized (b)(4) 2011.The data presented is from three different product applications.The report sates that there are no significant trends.It is noted that there are blank areas on this form, the info was not provided or is unk.
|